Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody‐mediated immune suppression and prevention of severe clinical complications in a murine model
Authors:
- Mette Kjaer KillieMKMette Kjaer Killie
- Pingguo ChenPCPingguo Chen
- Mariana EksteenMEMariana Eksteen
- Anne HusebekkAHAnne Husebekk
- Bjorn SkogenBSBjorn Skogen
- Jens Kjeldsen‐KraghJKJens Kjeldsen‐Kragh
- Heyu NiHNHeyu Ni
- 17 January 2012
- journal article
- Published by Wiley in Transfusion
- Vol. 52 (7) , 1446-1457
Abstract
BACKGROUND: Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a severe bleeding disorder caused by maternal antibody–mediated destruction of fetal or neonatal platelets (PLTs). Results from our recent large screening study suggest that the pathophysiology of FNAIT is more similar to hemolytic disease of the fetus and newborn (HDFN) than previously thought. Immunization against HPA‐1a might therefore be preventable by a prophylactic regimen of inducing antibody‐mediated immune suppression (AMIS), which has been documented to be a useful prophylaxis against HDFN. This preclinical proof‐of‐concept study investigated whether passive administration of anti‐β3 integrin could induce AMIS and thereby prevent clinical complications of FNAIT.STUDY DESIGN AND METHODS: A murine model of FNAIT using β3 integrin (GPIIIa)‐deficient (β3−/−) mice was employed for this study. AMIS in β3−/− mice was induced by intravenous administration of human anti‐HPA‐1a immunoglobulin G or murine anti‐β3 antisera given as prophylaxis after transfusion of HPA‐1a–positive human PLTs or murine wild‐type PLTs, respectively.RESULTS: AMIS against both human and murine PLT antigens was induced using this prophylactic approach, reducing the amount of maternal PLT antibodies by up to 90%. Neonatal PLT counts were significantly increased and pregnancy outcome was improved in a dose‐dependent manner. The incidence of intracranial hemorrhage, miscarriage, and dead‐born pups in mice receiving high‐dose prophylaxis was reduced to that of normal controls. We also observed that the severity of thrombocytopenia inversely correlated with birth weight.CONCLUSION: This work conceptually proves that prophylactic administration of PLT antibodies induces AMIS and prevents poor pregnancy outcome in FNAIT.Keywords
This publication has 39 references indexed in Scilit:
- The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapiesJournal of Clinical Investigation, 2011
- Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapyBlood, 2010
- Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Transfusion of antibody‐opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine modelTransfusion, 2010
- Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disordersTransfusion, 2010
- Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newbornHematology-American Society Hematology Education Program, 2009
- Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newbornClinical and Experimental Immunology, 2008
- A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newbornHaematologica, 2008
- The natural history of maternal immunization against foetal platelet alloantigensTransfusion Medicine, 2004
- Non‐Determinant Specificity of Feedback Immunosuppression by IgG Antibodies Injected after the AntigenScandinavian Journal of Immunology, 1988